New Delhi; 17th November 2022.
An Indian Medtech Start-up Company is
ready to conquer the global market. India’s SS Innovation has now gained access to global capital & market through
acquisition of controlling interest in Avra Medical Robotics, a Nasdaq listed
company in United States.It is to mention that the ingenious
SSI Mantra, a brainchild of World-renowned robotic cardiac surgeon Dr.
Sudhir P Srivastava, has introduced a new era of surgical procedures in
India, making robotic surgery accessible and affordable for the people of
our country.Good Healthcare will no
longer be a privilege for limited few but will be accessible to all!
Dr. Frederic Moll, The father of Robotic surgery, graced the announcement programme as the “Guest of Honour”. Dr. Moll,is a founder of World’s first surgical
robot , Da Vinci surgical system, and is a World renowned medical device
developer and entrepreneur, specialising in Robotic Surgery. He emphasised on
the importance of robotic surgery and multiple benefits of these procedure over
the traditional surgical methodology.
Dr. Fredric Moll, Founder- Intuitive Surgical said:“Very excited to be here to witness the
progress and development of a new robotic system that I believe is a great step
forward for the general distribution of healthcare in the field of medical
surgery. This system will provide the most advanced technology to the patients
around the globe, East and West alike. This technology is an opportunity to
bring a major impact on contributing towards better healthcare and wellbeing of
Asia and across her borders.”
SS Innovations has made the
nation proud, being the first company in
South Asia to launch first fully
“Made in India” surgical robot SSI Mantra, a technologically advanced surgical robotic system that has
more andbetter features and applications than
existing systems. This machine will revolutionize the idea of surgical
practices in our homeland and around the world in termsofprecision,technicaladvancement,andcostreduction,makingexpensiveroboticsurgeryavailableforthecommonpeople.
On this momentous occasion Dr. Sudhir P Srivastava, Founder, Chairman&
CEO, SS Innovations said “This acquisition will help us reach to global
market. Our innovation will be used widely. As we know that future of Medtech
lies on the precision of surgery and this acquisition will help us to bring
this ‘Make in India’ technology on the global platform. The union of Avra Medical
Robotics with SSI will revolutionise the
medical service all over the world hailing the spirit of Made in India,
Atmanirbhar Bharat. We are very happy today to have some distinguished
personalities with us like Dr. Moll, father of Robotics Surgery. The vision He had
some 25 years back is now being manifested in full-fledged expression. We are
all proud to be a part of this project. An Indian MedTech start-up will be
there on NASDAQ, is definitely a proud moment for the entire nation.”
Bryan Knodel, highly experienced and
accomplished medical robotics scientist and Barry F Cohen, founder, chairman
and CEO of Avra Medical Robotics Inc., USA were also present on the occasion of
this important announcement.
On this merger, Barry F Cohen, founder, chairman and CEO of Avra Medical Robotics Inc.,
USA said, “It is wonderful to be here in India. I have visited this country
many times over the last fifty years. Today stands as the No. One occasion for
me so far. It is bringing together so much of my history, work and medicine. I
am so happy for taking along my company Avra
Medical Robotics into a marriage with Dr. Srivastava's SSI Innovations. We
have combined the gifts of East and the West to bringing extremely accurate
precision of Surgery to the people of the World. It is a good fortune; we wish
to share to the people. Good luck!
Avra Medical
Robotics is pushing the transition from assistive to semi-autonomous treatments
in healthcare with an initial focus on aesthetics. The company is constantly
working on semi-autonomous systems. The Avra Robotic Treatment System (ARTS)
allows for providers to view a treatment plan and watch the treatment be
performed purely by the robot using the advanced guidance technology. With
precision scanning, artificial intelligence, targeting, treatment, and information
collection, their system provides boundless diagnostic and therapeutic
implications for the healthcare space to target, diagnose, and treat.
With this merger,
a new era of healthcare will soon be witnessed which will revolutionize the future of robotic surgeries across the
Globe.